Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

JDD: Celebrating 10 Years of Publishing Excellence

By No Comments
Flor A. Mayoral MDFlor A. Mayoral MD has been practicing in South Florida for 27 years. Dr. Mayoral is board certified by the American Academy of Dermatology (AAD) and the…
Read More
Dec 10
Love0

Message from the Guest Editor

By No Comments
Just 10 years ago, studies were being published on biologics for psoriasis, new promising steps forward. At that time, one author wrote that biologics “provide only modest efficacy compared with…
Read More
Dec 10
Love0

The Safety of Ustekinumab in Psoriasis

By No Comments
INTRODUCTION The efficacy of ustekinumab in treating psoriasis has been demonstrated in Phase I through Phase III trials.1-6 Ustekinumab is a human monoclonal antibody that binds to the shared p40…
Read More
Dec 10
Love0

JAK Inhibitors in Psoriasis: A Promising New Treatment Modality

By No Comments
INTRODUCTION Janus kinases are a key component of the molecular machinery involved in signal transduction through various cytokine receptors.1 Janus kinases, which are associated with the cytoplasmic domain of cytokine…
Read More
Dec 10
Love0

Digital Videography Assessment of Patients’ Experiences Using Adapalene-Benzoyl Peroxide Gel in the Treatment of Acne Vulgaris

By No Comments
INTRODUCTION Acne is a chronic condition with a prolonged course, slow onset, acute outbreaks, and a pattern of recurrence and relapse.1,2 Acne can have psychological and social consequences, 3 like…
Read More
Dec 10
Love0

A Randomized Controlled Study of Combination Therapy With Alefacept and Narrow Band UVB Phototherapy (UVB) for Moderate to Severe Psoriasis: Efficacy, Onset, and Duration of Response

By No Comments
INTRODUCTION Psoriasis is a T-lymphocyte (T-cell) mediated inflammatory skin disorder with an estimated prevalence of 1% to 3%,1 with up to one-third of affected individuals exhibiting moderate to severe disease.2…
Read More
Dec 10
Love0

Treatment of Nail Psoriasis With TNF-α or IL12/23 Inhibitors

By No Comments
INTRODUCTION Psoriasis is a common skin disease with a significant negative impact on health as well as quality of life and cumulative life course.1,2,3 In addition to systemic co-morbidities and…
Read More
Dec 10
Love0

Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial

By No Comments
INTRODUCTION Psoriasis is a chronic, inflammatory, immune-mediated disease of the skin that is often associated with co-morbidities such as depression, psoriatic arthritis, diabetes, and cardiovascular disease.1-5 Psychosocial co-morbidities, which may…
Read More
Dec 10
Love0

Open Label Study to Evaluate the Efficacy of Re-Treatment With Etanercept in Patients With Psoriasis

By No Comments
INTRODUCTIONPsoriasis is a chronic, genetically determined, immune-mediated inflammatory skin disease affecting approximately 2% to 3% of the Caucasian population. Plaque type is the most common form, even though other forms…
Read More
Dec 10
Love0

Trends in Older Adult Psoriasis Outpatient Health Care Practices in the United States

By No Comments
INTRODUCTION As the baby-boomer generation (born between 1945 to 1965) has aged, the older adult population has become a prominent age group in the United States (US) and is expected…
Read More
Dec 10
Love0

Efficacy and Tolerability of Two Commercial Hyperpigmentation Kits in the Treatment of Facial Hyperpigmentation and Photo-Aging

By No Comments
INTRODUCTION Disorders of hyperpigmentation including melasma, solar lentigines, ephelides, postinflammatory hyperpigmentation (PIH), mottled pigmentation, and dyschromia of photo-aging are conditions commonly seen in clinical dermatology practices. These pigmentary disorders can…
Read More
Dec 10
Love0

Treatment With a Novel Topical Nanoemulsion (NB-001) Speeds Time to Healing of Recurrent Cold Sores

By No Comments
INTRODUCTION Herpes labialis is an exceedingly common condition caused by episodic reactivation of latent herpes simplex virus, type 1 (HSV-1) leading to recurrent painful and socially embarrassing lesions (cold sores).1-5…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis October 10, 2025
  • 1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use October 9, 2025
  • Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin October 8, 2025
  • In Memoriam: Ronald Moy MD (1957-2025) October 7, 2025
  • Study of Adjuvant Sensitive-Skin Cleansings and Moisturizing Regimen in Plaque Psoriasis October 6, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search